2026-02-03 12:15
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
https://www.cnbc.com/2026/02/03/pfizer-pfe-earnings-q4-2025.html
#cnbc
https://www.cnbc.com/2026/02/03/pfizer-pfe-earnings-q4-2025.html
#cnbc